Skip to main content

Table 3 Gestational diabetes and pre-eclamspia in the exercise and control groups, PAMELA study

From: A randomized controlled trial of exercise during pregnancy on maternal and neonatal outcomes: results from the PAMELA study

 

Intervention (n = 205) ǂ

Control (n = 407)

  
 

n (%)

p

OR (95%CI)

Intention-to-treat analysis

Gestational diabetes

  

0.93

 

 Yes

16 (7.8)

31 (7.6)

 

1.0 (0.6;1.9)

 No

189 (92.2)

376 (92.4)

 

Pre-eclampsia

  

0.98

 

 Yes

11 (5.4)

22 (5.4)

 

1.0 (0.5;2.1)

 No

194 (94.6)

385 (94.6)

 

Per protocol analysis (> = 70% exercise sessions)

n=85a

n = 407

  
 

n (%)

 

OR (95%CI)P

Gestational diabetes

  

0.85

 

 Yes

7 (8.2)

31 (7.6)

 

1.1 (0.5;2.6)

 No

78 (91.8)

376 (92.4)

 

Pre-eclampsia

  

0.79

 

 Yes

4 (4.7)

22 (5.4)

 

0.9 (0.3;2.6)

 No

81 (95.3)

385 (94.6)

 

Sensitivity analysis (per protocol 100%)1

n = 23

n = 407

  
 

n (%)

 

OR (95%CI)

Gestational diabetes

  

0.56

 

 Yes

1 (4.4)

31 (7.6)

 

0.6 (0.1-4.2)

 No

22 (95.6)

376 (92.4)

 

Pre-eclampsia

  

0.25

 

 Yes

0

22 (5.4)

 

 No

23 (100.0)

385 (94.6)

 

  1. Data are expressed as number of cases in frequencies absolute and relative (n, %). p > .05; OR: odds ratio; CI: confidence interval. aAt least 48 sessions of the total exercise program
  2. ǂ8 participants in the intervention group did not attend the perinatal follow-up
  3. 19 participants in the control group did not attend the perinatal follow-up
  4. a1 participant adherent to the PAMELA protocol did not attend the perinatal follow-up